Zwipe AS (ZWIPE.OL)
NOK 0.03
(0.0%)
NOK 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -92.29 Million | -108.13 Million | -76.69 Million | -59.83 Million | -80.36 Million | -50.37 Million |
| Net Income | -100.03 Million | -104.78 Million | -83.47 Million | -62.07 Million | -95.15 Million | -72.04 Million |
| Depreciation & Amortization | 2.56 Million | 1.87 Million | 8.39 Million | 2 Million | 3.3 Million | 8.03 Million |
| Deferred income taxes | -16.26 Million | -14.69 Million | - | -1.88 Million | -3.78 Million | -6.42 Million |
| Stock-based compensation | 4.95 Million | 3.67 Million | 4 Million | 1.88 Million | 3.88 Million | 5.8 Million |
| Change in working capital | 221 Thousand | -8.89 Million | -5.52 Million | -1.65 Million | 7.51 Million | 8.46 Million |
| Other non-cash items | 16.26 Million | 14.69 Million | -92 Thousand | 1.88 Million | 3.88 Million | 5.8 Million |
| Investing Cash Flow | -2.14 Million | -1.45 Million | -1.71 Million | -2.25 Million | -4.63 Million | -6.35 Million |
| Investments in PPE | -2.14 Million | -1.45 Million | -1.71 Million | -2.25 Million | -4.63 Million | -6.35 Million |
| Acquisitions | - | - | - | - | 419 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.14 Million | - | - | - | -419 Thousand | - |
| Financing Cash Flow | 86.77 Million | 5.09 Million | 105.24 Million | 164.47 Million | 97.42 Million | 18.51 Million |
| Debt repayment | -10.51 Million | - | - | -3.06 Million | -15.25 Million | -12.47 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -67 Million | - |
| Common Stock Issuance | 100.13 Million | 5.13 Million | 105.19 Million | 177.72 Million | 187.07 Million | 20 Million |
| Other Financing Activities | -2.85 Million | -41 Thousand | 54 Thousand | -10.18 Million | 68.98 Million | 10.99 Million |
| Accounts receivables | 2.73 Million | -2.02 Million | 3000.00 | 255 Thousand | 1.91 Million | -1.83 Million |
| Accounts payables | 4.78 Million | 2.46 Million | -2.26 Million | -7.54 Million | 2.86 Million | 4.27 Million |
| Inventory | -13.7 Million | -7.7 Million | -2.13 Million | 2.79 Million | -797 Thousand | 2.83 Million |
| Other working capital | 6.4 Million | -1.63 Million | -1.13 Million | 2.84 Million | 3.53 Million | 5.63 Million |
| Cash at beginning of period | 50.46 Million | 152.34 Million | 125.25 Million | 23.23 Million | 10.79 Million | 49.26 Million |
| Cash at end of period | 42.2 Million | 50.46 Million | 152.34 Million | 125.25 Million | 23.23 Million | 10.79 Million |
| Capital Expenditure | -2.14 Million | -1.45 Million | -1.71 Million | -2.25 Million | -4.63 Million | -6.35 Million |
| Effect of forex changes on cash | -594 Thousand | 2.6 Million | 249 Thousand | -365 Thousand | 10 Thousand | -257 Thousand |
| Net cash flow / Change in cash | -8.26 Million | -101.88 Million | 27.09 Million | 102.01 Million | 12.43 Million | -38.46 Million |
| Free Cash Flow | -94.43 Million | -109.58 Million | -78.4 Million | -62.09 Million | -84.99 Million | -56.72 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.99 Million | -14.99 Million | -100.03 Million | -43.89 Million | -21.94 Million | -56.14 Million |
| Depreciation & Amortization | 365.5 Thousand | 365.5 Thousand | 2.56 Million | 1.55 Million | 777 Thousand | 1.01 Million |
| Deferred income taxes | - | - | -16.26 Million | -11.78 Million | - | -2 Million |
| Stock-based compensation | - | - | 4.95 Million | 1.8 Million | 1.8 Million | 669.5 Thousand |
| Change in working capital | -2.34 Million | -2.34 Million | 221 Thousand | 4.1 Million | 1.99 Million | -3.88 Million |
| Other non-cash items | -3.17 Million | -3.17 Million | 16.26 Million | 13.59 Million | 62.5 Thousand | 2.67 Million |
| Investing Cash Flow | -284.5 Thousand | -284.5 Thousand | -2.14 Million | -398 Thousand | -199 Thousand | -1.74 Million |
| Investments in PPE | -284.5 Thousand | -284.5 Thousand | -2.14 Million | -398 Thousand | -199 Thousand | -1.74 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 12.1 Million | 12.1 Million | 86.77 Million | 2.68 Million | 1.34 Million | 84.09 Million |
| Debt repayment | - | - | -10.51 Million | -10.51 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -500.00 | -500.00 | - |
| Common Stock Issuance | 24.4 Million | - | 100.13 Million | -1000.00 | - | 100.13 Million |
| Other Financing Activities | 12.1 Million | 12.1 Million | -2.85 Million | -7.83 Million | 1.34 Million | -16.04 Million |
| Accounts receivables | -158 Thousand | -158 Thousand | 2.73 Million | 2.08 Million | 1.04 Million | 647 Thousand |
| Accounts payables | -6.41 Million | - | 4.78 Million | 124 Thousand | - | 4.66 Million |
| Inventory | 171.5 Thousand | 171.5 Thousand | -13.7 Million | -9.08 Million | -4.54 Million | -4.62 Million |
| Other working capital | -2.35 Million | -2.35 Million | 6.4 Million | 10.97 Million | 5.48 Million | -4.57 Million |
| Cash at beginning of period | 42.2 Million | - | 50.46 Million | 75.96 Million | - | 50.46 Million |
| Cash at end of period | 25.18 Million | -8.5 Million | 42.2 Million | 42.2 Million | -16.83 Million | 75.96 Million |
| Capital Expenditure | -284.5 Thousand | -284.5 Thousand | -2.14 Million | -398 Thousand | -199 Thousand | -1.74 Million |
| Effect of forex changes on cash | -171.5 Thousand | -171.5 Thousand | -594 Thousand | -663.5 Thousand | -663.5 Thousand | 366.5 Thousand |
| Net cash flow / Change in cash | -17.01 Million | -8.5 Million | -8.26 Million | -33.75 Million | -16.83 Million | 25.49 Million |
| Free Cash Flow | -20.43 Million | -20.43 Million | -94.43 Million | -35.01 Million | -17.5 Million | -59.42 Million |
SCLP
9031
IWS
BIOFILCHEM
LEOF
3266